Francis Knuettel II — SEC insider filings
SEC reporting owner CIK 1433316. 26 insider filings on record with FilingPulse; latest filed 2026-11-12.
Transaction summary — filings shown
Covers all 26 filings on record, filed 2020-12-22 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 2 filings — 17,200 shares, $15,999 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 1,500 shares, $40,265 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 38.
- Largest priced transaction: sale of 1,500 shares @ $26.84 ($40,265) in Pelthos Therapeutics Inc., filed 2026-05-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | CFO, Treas & Secty | 11 | 4 legs · 17,200 sh · $15,999 | 1 leg · 1,500 sh · $40,265 | 16 |
| Unrivaled Brands, Inc. (UNRV) | CEO and President, Director | 4 | — | — | 11 |
| Beeline Holdings, Inc. (BLNE) | Director | 4 | — | — | 4 |
| 180 Life Sciences Corp. (ATNF) | Director | 3 | — | — | 3 |
| OS Therapies Inc (OSTX) | Chief Financial Officer | 3 | — | — | 3 |
| SPLASH BEVERAGE GROUP, INC. (SBEV) | Director | 1 | — | — | 1 |
Insider filings — Francis Knuettel II
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 4 | OS Therapies Inc (OSTX) | Grant/award (A): 250,000 @ $0 · Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2026-10-30 | 4 | OS Therapies Inc (OSTX) | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2026-10-05 | 3 | OS Therapies Inc (OSTX) | Holdings only — no transactions reported | EDGAR |
| 2026-09-10 | 4 | Beeline Holdings, Inc. (BLNE) | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2026-06-10 | 4 | SPLASH BEVERAGE GROUP, INC. (SBEV) | Grant/award (A): 500,000 (derivative) | EDGAR |
| 2026-06-01 | 4 | Beeline Holdings, Inc. (BLNE) | Grant/award (A): 10,000 @ $0 | EDGAR |
| 2026-05-26 | 4 | Pelthos Therapeutics Inc. (PTHS) | Disposition to issuer (D): 13,947 @ $0 · Sale (S): 1,500 @ $26.84 · Grant/award (A): 59,500 (derivative) · Disposition to issuer (D): 42,500 (derivative) | EDGAR |
| 2026-04-01 | 4/A | Pelthos Therapeutics Inc. (PTHS) | Grant/award (A): 33,472 @ $0 | EDGAR |
| 2025-12-17 | 4 | Beeline Holdings, Inc. (BLNE) | Grant/award (A): 30,000 @ $0 | EDGAR |
| 2025-10-06 | 4 | Beeline Holdings, Inc. (BLNE) | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2025-07-07 | 4 | Pelthos Therapeutics Inc. (PTHS) | Grant/award (A): 33,472 (derivative) · Grant/award (A): 102,000 (derivative) | EDGAR |
| 2025-07-03 | 4 | Pelthos Therapeutics Inc. (PTHS) | Conversion (C): 10,000 @ $10 · Other (J): 10,000 (derivative) @ $0 · Conversion (C): 10,000 (derivative) @ $0 | EDGAR |
| 2025-04-15 | 4 | Channel Therapeutics Corp (CHRO) | Grant/award (A): 53,988 (derivative) | EDGAR |
| 2024-09-16 | 4 | Chromocell Therapeutics Corp (CHRO) | Purchase (P): 1,700 @ $0.97 · Purchase (P): 3,500 @ $0.97 | EDGAR |
| 2024-09-12 | 4 | Chromocell Therapeutics Corp (CHRO) | Purchase (P): 6,500 @ $0.89 · Purchase (P): 5,500 @ $0.94 | EDGAR |
| 2024-07-02 | 4 | Chromocell Therapeutics Corp (CHRO) | Gift (G): 5,000 @ $0 · Gift (G): 15,000 @ $0 | EDGAR |
| 2024-06-18 | 4/A | Chromocell Therapeutics Corp (CHRO) | Grant/award (A): 2,778 (derivative) | EDGAR |
| 2024-06-18 | 4 | Chromocell Therapeutics Corp (CHRO) | Grant/award (A): 27,778 (derivative) · Grant/award (A): 324,000 (derivative) | EDGAR |
| 2024-02-23 | 4 | Chromocell Therapeutics Corp (CHRO) | Grant/award (A): 2,778 (derivative) | EDGAR |
| 2023-09-08 | 4 | 180 Life Sciences Corp. (ATNF) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-05-23 | 4 | 180 Life Sciences Corp. (ATNF) | Grant/award (A): 21,000 (derivative) @ $0 | EDGAR |
| 2021-08-05 | 4 | 180 Life Sciences Corp. (ATNF) | Grant/award (A): 79,000 (derivative) @ $0 | EDGAR |
| 2021-07-12 | 4/A | Unrivaled Brands, Inc. (UNRV) | Grant/award (A): 1,500,000 @ $0 | EDGAR |
| 2021-07-12 | 4 | Unrivaled Brands, Inc. (UNRV) | Grant/award (A): 423,456 · Grant/award (A): 200,000 @ $0 · Grant/award (A): 400,000 @ $0 · Grant/award (A): 769,290 (derivative) · Grant/award (A): 192,322 (derivative) · Grant/award (A): 192,322 (derivative) | EDGAR |
| 2021-06-09 | 4 | Terra Tech Corp. (TRTC) | Grant/award (A): 1,500,000 @ $0.23 · Grant/award (A): 1,500,000 (derivative) @ $0 | EDGAR |
| 2020-12-22 | 4 | Terra Tech Corp. (TRTC) | Grant/award (A): 200,000 @ $0.18 · Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1433316 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs